Publications
-
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.
Metzger ML,
Weinstein HJ, Hudson MM, Billett AL, Larsen EC, Friedmann A, Howard SC, Donaldson SS, Krasin MJ, Kun LE, Marcus KJ, Yock TI, Tarbell N, Billups CA, Wu J, Link MP.
JAMA.
2012;
307
(24):
2609-16
-
The impact of drug shortages on children with cancer--the example of mechlorethamine.
Metzger ML,
Billett A, Link MP.
N Engl J Med.
2012;
367
(26):
2461-3
-
Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
O'Brien MM,
Donaldson SS, Balise RR, Whittemore AS, Link MP.
J Clin Oncol.
2010;
28
(7):
1232-9
-
ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/Akt activity with retained but inactivated PTEN--a report from the Children's Oncology Group.
Thakral C,
Hutchison RE, Shrimpton A, Barrett D, Laver J, Link M, Halleran DR, Hudson S.
Pediatr Blood Cancer.
2012;
59
(3):
440-7
-
Adolescent and young adult oncology. Clinical practice guidelines in oncology.
Coccia PF,
Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Pappo AS, Reed D, Spraker HL, Thomas DA, von Mehren M, Wechsler DS, Whelan KF, Zebrack BJ, Sundar H, Shead DA.
J Natl Compr Canc Netw.
2012;
10
(9):
1112-50
-
Chemotherapy drug shortages in the United States: genesis and potential solutions.
Link MP,
Hagerty K, Kantarjian HM.
J Clin Oncol.
2012;
30
(7):
692-4
-
Complete ocular paresis in a child with posterior fossa syndrome.
Afshar M,
Link M, Edwards MS, Fisher PG, Fredrick D, Monje M.
Pediatr Neurosurg.
2012;
48
(1):
51-4
-
Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study.
Schüz J,
Grell K, Kinsey S, Linet MS, Link MP, Mezei G, Pollock BH, Roman E, Zhang Y, McBride ML, Johansen C, Spix C, Hagihara J, Saito AM, Simpson J, Robison LL, Dockerty JD, Feychting M, Kheifets L, Frederiksen K.
Blood Cancer J.
2012:
2
e98
-
The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards.
Goss E,
Link MP, Bruinooge SS, Lawrence TS, Tepper JE, Runowicz CD, Schilsky RL.
J Clin Oncol.
2009;
27
(24):
4014-20
-
Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings.
Woolf KM,
Wei MC, Link MP, Arber DA, Warnke RA.
Appl Immunohistochem Mol Morphol.
2008;
16
(2):
196-201
-
Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study.
Hutchison RE,
Laver JH, Chang M, Muzzafar T, Desai S, Murphy S, Schwenn M, Shuster J, Link MP.
Pediatr Blood Cancer.
2008;
51
(1):
29-33
-
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA,
Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE.
J Clin Oncol.
2008;
26
(4):
633-8
-
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
Donaldson SS,
Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM.
J Clin Oncol.
2007;
25
(3):
332-7
-
Magnetic field exposure and prognostic factors in childhood leukemia.
Foliart DE,
Mezei G, Iriye R, Silva JM, Ebi KL, Kheifets L, Link MP, Kavet R, Pollock BH.
Bioelectromagnetics.
2007;
28
(1):
69-71
-
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Bhatia S,
Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, Rausen AR, Robison LL, Vietti TJ, Miser JS.
Blood.
2007;
109
(1):
46-51
-
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
Miser JS,
Goldsby RE, Chen Z, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore SG, Rausen AR, Vietti TJ, Grier HE.
Pediatr Blood Cancer.
2007;
49
(7):
894-900
-
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.
Bernstein ML,
Devidas M, Lafreniere D, Souid AK, Meyers PA, Gebhardt M, Stine K, Nicholas R, Perlman EJ, Dubowy R, Wainer IW, Dickman PS, Link MP, Goorin A, Grier HE.
J Clin Oncol.
2006;
24
(1):
152-9
-
Magnetic field exposure and long-term survival among children with leukaemia.
Foliart DE,
Pollock BH, Mezei G, Iriye R, Silva JM, Ebi KL, Kheifets L, Link MP, Kavet R.
Br J Cancer.
2006;
94
(1):
161-4
-
Review of tonsillar lymphoma in pediatric patients from the pediatric oncology group: what can be learned about some indications for microscopic examination?
Sayed K,
Van Savell H, Hutchison RE, Kepner J, Link MP, Schwenn M, Mahmoud H, Parham DM.
Pediatr Dev Pathol.
2005 Sep-Oct;
8
(5):
533-40
-
Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature.
George TI,
Jeng M, Berquist W, Cherry AM, Link MP, Arber DA.
Pediatr Blood Cancer.
2005;
44
(3):
270-6
-
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
Meyers PA,
Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H.
J Clin Oncol.
2005;
23
(9):
2004-11
-
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Spunt SL,
Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM, Link MP.
Clin Cancer Res.
2004;
10
(18 Pt 1):
6072-9
-
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
Crews KR,
Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.
Cancer.
2004;
100
(8):
1724-33
-
High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices.
Lieskovsky YE,
Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP, Agarwal R.
J Clin Oncol.
2004;
22
(22):
4532-40
-
National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002.
Patrick DL,
Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Reid LD, Turrisi AT, Unützer J, Vernon SW.
J Natl Cancer Inst Monogr.
2004;
(32):
9-16
-
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
Hudson MM,
Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowan T, Weinstein HJ.
J Clin Oncol.
2004;
22
(22):
4541-50
-
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS,
Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE.
J Clin Oncol.
2004;
22
(14):
2873-6
-
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE,
Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS.
N Engl J Med.
2003;
348
(8):
694-701
-
National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002.
Patrick DL,
Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Ried LD, Turrisi AT, Unützer J, Vernon SW.
J Natl Cancer Inst.
2003;
95
(15):
1110-7
-
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Goorin AM,
Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE, Link MP.
J Clin Oncol.
2003;
21
(8):
1574-80
-
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.
Breneman JC,
Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, Paidas CN, Crist WM.
J Clin Oncol.
2003;
21
(1):
78-84
-
Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
Smith RS,
Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS.
J Clin Oncol.
2003;
21
(10):
2026-33
-
National action plan for childhood cancer: report of the national summit meetings on childhood cancer.
Arceci R,
Ettinger A, Forman E, Haase GM, Hammond GD, Hoffman R, Kupst MJ, Link MP, Lustig CP, Traynor DS.
CA Cancer J Clin.
2002 Nov-Dec;
52
(6):
377-9
-
Assessment of lymphadenopathy in children.
Twist CJ,
Link MP.
Pediatr Clin North Am.
2002;
49
(5):
1009-25
-
Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study.
Winter SS,
Sweatman J, Shuster JJ, Link MP, Amylon MD, Pullen J, Camitta BM, Larson RS.
Leukemia.
2002;
16
(6):
1121-6
-
Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.
Baker KS,
Anderson JR, Lobe TE, Wharam MD, Qualman SJ, Raney RB, Ruymann FB, Womer RB, Meyer WH, Link MP, Crist WM.
J Clin Oncol.
2002;
20
(22):
4428-33
-
Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study.
Marina NM,
Cochrane D, Harney E, Zomorodi K, Blaney S, Winick N, Bernstein M, Link MP.
Clin Cancer Res.
2002;
8
(2):
413-8
-
Minimax two-stage-designs with applications to tissue banking case-control studies.
Shuster J,
Link M, Camitta B, Pullen J, Behm F.
Stat Med.
2002;
21
(17):
2479-93
-
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
Goorin AM,
Harris MB, Bernstein M, Ferguson W, Devidas M, Siegal GP, Gebhardt MC, Schwartz CL, Link M, Grier HE.
J Clin Oncol.
2002;
20
(2):
426-33
-
Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation.
Friedmann AM,
Hudson MM, Weinstein HJ, Donaldson SS, Kun L, Tarbell NJ, Link MP.
J Clin Oncol.
2002;
20
(14):
3088-94
-
VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.
Donaldson SS,
Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, Marcus KC, Hurwitz CA, Young JA, Tarbell NJ, Weinstein HJ.
J Clin Oncol.
2002;
20
(14):
3081-7
-
Thyroid carcinoma after successful treatment of osteosarcoma: a report of three patients.
Verneris M,
McDougall IR, Becton D, Link MP.
J Pediatr Hematol Oncol.
2001 Jun-Jul;
23
(5):
312-5
-
Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial.
Ferguson WS,
Harris MB, Goorin AM, Gebhardt MC, Link MP, Shochat SJ, Siegal GP, Devidas M, Grier HE.
J Pediatr Hematol Oncol.
2001 Aug-Sep;
23
(6):
340-8
-
Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey.
Hilden JM,
Emanuel EJ, Fairclough DL, Link MP, Foley KM, Clarridge BC, Schnipper LE, Mayer RJ.
J Clin Oncol.
2001;
19
(1):
205-12
-
Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?
Wiener ES,
Anderson JR, Ojimba JI, Lobe TE, Paidas C, Andrassy RJ, Raney RB, Qualman SJ, Donaldson SS, Maurer HM, Link MP, Crist WM, Grier HE.
Semin Pediatr Surg.
2001;
10
(3):
146-52
-
Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.
Sandler E,
Lyden E, Ruymann F, Maurer H, Wharam M, Parham D, Link M, Crist W.
Med Pediatr Oncol.
2001;
37
(5):
442-8
-
What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
Arndt CA,
Donaldson SS, Anderson JR, Andrassy RJ, Laurie F, Link MP, Raney RB, Maurer HM, Crist WM.
Cancer.
2001;
91
(12):
2454-68
-
Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
Smith LM,
Anderson JR, Qualman SJ, Crist WM, Paidas CN, Teot LA, Pappo AS, Link MP, Grier HE, Wiener ES, Breneman JC, Raney RB, Maurer HM, Donaldson SS.
J Clin Oncol.
2001;
19
(20):
4058-64
-
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Baker KS,
Anderson JR, Link MP, Grier HE, Qualman SJ, Maurer HM, Breneman JC, Wiener ES, Crist WM.
J Clin Oncol.
2000;
18
(12):
2427-34
-
Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
Hutchison RE,
Finch C, Kepner J, Fuller C, Bowman P, Link M, Schwenn M, Laver J, Desai S, Barrett D, Murphy SB.
Ann Oncol.
2000:
11 Suppl 1
35-8
-
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
Laver JH,
Barredo JC, Amylon M, Schwenn M, Kurtzberg J, Camitta BM, Pullen J, Link MP, Borowitz M, Ravindranath Y, Murphy SB, Shuster J.
Leukemia.
2000;
14
(3):
369-73
-
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.
Schneider NR,
Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ, Camitta BM, Katz JA, Amylon MD.
Blood.
2000;
96
(7):
2543-9
-
Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience.
Navid F,
Mosijczuk AD, Head DR, Borowitz MJ, Carroll AJ, Brandt JM, Link MP, Rozans MK, Thomas GA, Schwenn MR, Shields DJ, Vietti TJ, Pullen DJ.
Leukemia.
1999;
13
(1):
135-41
-
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
Rubnitz JE,
Camitta BM, Mahmoud H, Raimondi SC, Carroll AJ, Borowitz MJ, Shuster JJ, Link MP, Pullen DJ, Downing JR, Behm FG, Pui CH.
J Clin Oncol.
1999;
17
(1):
191-6
-
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.
Amylon MD,
Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta B, Murphy SB.
Leukemia.
1999;
13
(3):
335-42
-
Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study.
Pullen J,
Shuster JJ, Link M, Borowitz M, Amylon M, Carroll AJ, Land V, Look AT, McIntyre B, Camitta B.
Leukemia.
1999;
13
(11):
1696-707
-
Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study.
Suryanarayan K,
Shuster JJ, Donaldson SS, Hutchison RE, Murphy SB, Link MP.
J Clin Oncol.
1999;
17
(2):
456-9
-
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
Donaldson SS,
Torrey M, Link MP, Glicksman A, Gilula L, Laurie F, Manning J, Neff J, Reinus W, Thompson E, Shuster JJ.
Int J Radiat Oncol Biol Phys.
1998;
42
(1):
125-35
-
E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.
Hunger SP,
Fall MZ, Camitta BM, Carroll AJ, Link MP, Lauer SJ, Mahoney DH, Pullen DJ, Shuster JJ, Steuber CP, Cleary ML.
Blood.
1998;
91
(3):
1021-8
-
Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study.
Laver J,
Amylon M, Desai S, Link M, Schwenn M, Mahmoud H, Shuster J.
J Clin Oncol.
1998;
16
(2):
522-6
-
Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.
Harris MB,
Gieser P, Goorin AM, Ayala A, Shochat SJ, Ferguson WS, Holbrook T, Link MP.
J Clin Oncol.
1998;
16
(11):
3641-8
-
A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study.
Arndt C,
Tefft M, Gehan E, Anderson J, Jenson M, Link M, Donaldson S, Breneman J, Wiener E, Webber B, Maurer H.
J Pediatr Hematol Oncol.
1997 Mar-Apr;
19
(2):
124-9
-
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.
Marks DI,
Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Carroll D, Brodsky I, Haines DS.
J Clin Oncol.
1997;
15
(3):
1158-62
-
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study.
Rubnitz JE,
Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM, Pui CH, Downing JR, Behm FG.
Blood.
1997;
89
(4):
1143-6
-
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group.
Brecher ML,
Schwenn MR, Coppes MJ, Bowman WP, Link MP, Berard CW, Shuster JJ, Murphy SB.
Med Pediatr Oncol.
1997;
29
(6):
526-33
-
Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
Batova A,
Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL.
Cancer Res.
1997;
57
(5):
832-6
-
Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemia.
Maloney KW,
Rubnitz JE, Cleary ML, Frankel LS, Hakami N, Link MP, Pullen DJ, Hunger SP.
Leukemia.
1997;
11
(7):
979-83
-
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
Link MP,
Shuster JJ, Donaldson SS, Berard CW, Murphy SB.
N Engl J Med.
1997;
337
(18):
1259-66
-
Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.
Hutchison RE,
Banki K, Shuster JJ, Barrett D, Dieck C, Berard CW, Murphy SB, Link MP, Pick TE, Laver J, Schwenn M, Mathew P, Morris SW.
Ann Oncol.
1997:
8 Suppl 1
37-42
-
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis.
Marks DI,
Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Brodsky I, Haines DS.
Blood.
1996;
87
(3):
1155-61
-
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
Bowman WP,
Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, Link M, Head D, Carroll A, Berard C, Murphy S.
J Clin Oncol.
1996;
14
(4):
1252-61
-
NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network.
O'Reilly R,
Link M, Fletcher B, Gebhardt M, Krance R, Meyers P, Neff J, Schwartz C.
Oncology (Williston Park).
1996;
10
(12):
1799-806, 1812
-
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Smith M,
Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R.
J Clin Oncol.
1996;
14
(1):
18-24
-
B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study.
Hutchison RE,
Berard CW, Shuster JJ, Link MP, Pick TE, Murphy SB.
J Clin Oncol.
1995;
13
(8):
2023-32
-
Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
Goorin A,
Strother D, Poplack D, Letvak LA, George M, Link M.
Med Pediatr Oncol.
1995;
24
(6):
362-7
-
Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ,
Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C.
Exp Hematol.
1995;
23
(11):
1160-6
-
Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study.
Harris MB,
Cantor AB, Goorin AM, Shochat SJ, Ayala AG, Ferguson WS, Holbrook T, Link MP.
Med Pediatr Oncol.
1995;
24
(2):
87-92
-
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
Hunger SP,
Link MP, Donaldson SS.
J Clin Oncol.
1994;
12
(10):
2160-6
-
Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study.
Perlman EJ,
Dickman PS, Askin FB, Grier HE, Miser JS, Link MP.
Hum Pathol.
1994;
25
(3):
304-7
-
Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Rubnitz JE,
Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML.
Blood.
1994;
84
(2):
570-3
-
Hodgkin's disease in the very young.
Cleary SF,
Link MP, Donaldson SS.
Int J Radiat Oncol Biol Phys.
1994;
28
(1):
77-83
-
Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study.
Jacknow DS,
Tschann JM, Link MP, Boyce WT.
J Dev Behav Pediatr.
1994;
15
(4):
258-64
-
MIC2 analysis in pediatric lymphomas and leukemias.
Riopel M,
Dickman PS, Link MP, Perlman EJ.
Hum Pathol.
1994;
25
(4):
396-9
-
Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493).
Pettenati MJ,
Rao N, Wofford M, Shuster JJ, Pullen DJ, Ling MP, Steuber CP, Carroll AJ.
Cancer Genet Cytogenet.
1994;
75
(1):
6-10
-
Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations.
Russo CL,
McIntyre J, Goorin AM, Link MP, Gebhardt MC, Friend SH.
Med Pediatr Oncol.
1994;
23
(4):
354-8
-
Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome.
Fizzotti M,
Chen EY, Link MP, Carroll AJ, Foroni L, Rabbitts TH, Crist WM, Clark SS.
Leukemia.
1994;
8
(7):
1124-30
-
A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias.
Morrissey J,
Tkachuk DC, Milatovich A, Francke U, Link M, Cleary ML.
Blood.
1993;
81
(5):
1124-31
-
Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.
Hudson MM,
Weinstein HJ, Donaldson SS, Greenwald C, Kun L, Tarbell NJ, Humphrey WA, Rupp C, Marina NM, Wilimas J.
J Clin Oncol.
1993;
11
(6):
1080-4
-
Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study.
Bash RO,
Crist WM, Shuster JJ, Link MP, Amylon M, Pullen J, Carroll AJ, Buchanan GR, Smith RG, Baer R.
Blood.
1993;
81
(8):
2110-7
-
Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction.
Downing JR,
Head DR, Parham DM, Douglass EC, Hulshof MG, Link MP, Motroni TA, Grier HE, Curcio-Brint AM, Shapiro DN.
Am J Pathol.
1993;
143
(5):
1294-300
-
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
Hunger SP,
Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML.
Blood.
1993;
81
(12):
3197-203
-
Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity.
Ramani P,
Rampling D, Link M.
Histopathology.
1993;
23
(6):
557-61
-
Laboratory-clinical interface.
Link MP,
Stevens J, Friend SH, Israel MA, Knudson AG, Sondel PM.
Cancer.
1993;
71
(10 Suppl):
3219-21
-
Langerhans' cell histiocytosis presenting with the superior vena cava syndrome: a case report.
Mogul M,
Hartman G, Donaldson S, Gelb A, Link M, Amylon M, Glader B.
Med Pediatr Oncol.
1993;
21
(6):
456-9
-
Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy.
Link MP,
Cancer Treat Res.
1993:
62
383-5
-
The multi-institutional osteosarcoma study: an update.
Link MP,
Cancer Treat Res.
1993:
62
261-7
-
A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
Vats T,
Buchanan G, Mehta P, Ragab A, Hvizdale E, Nitschke R, Link M, Beardsley GP, Maybee D, Krischer J.
Invest New Drugs.
1992;
10
(3):
231-4
-
Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature.
Hunger SP,
Sklar J, Link MP.
J Clin Oncol.
1992;
10
(1):
156-63
-
Childhood malignant non-Hodgkin lymphomas of uncommon histology.
Ribeiro RC,
Pui CH, Murphy SB, Shuster JJ, Hvizdala EV, Falletta J, Link MP, Sullivan MP, Pick TE, Sandlund JT.
Leukemia.
1992;
6
(8):
761-5
-
Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist W,
Shuster J, Look T, Borowitz M, Behm F, Bowman P, Frankel L, Pullen J, Krance R, Steuber P.
Leukemia.
1992:
6 Suppl 2
162-6
-
Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze.
Grier HE,
Gelber RD, Link MP, Camitta BP, Clavell LA, Weistein HJ.
Leukemia.
1992:
6 Suppl 2
48-51
-
Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases.
Pui CH,
Carroll AJ, Raimondi SC, Schell MJ, Head DR, Shuster JJ, Crist WM, Borowitz MJ, Link MP, Behm FG.
Blood.
1992;
79
(9):
2384-91
-
Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study.
Abshire TC,
Buchanan GR, Jackson JF, Shuster JJ, Brock B, Head D, Behm F, Crist WM, Link M, Borowitz M.
Leukemia.
1992;
6
(5):
357-62
-
Osteosarcoma: good news despite crude tools.
Simone JV,
Meyer WH, Link MP.
J Clin Oncol.
1992;
10
(1):
1-2
-
t(2;14)(p13;q32): a recurring abnormality in lymphocytic leukemia. A Pediatric Oncology Group study.
Watson MS,
Land VJ, Carroll AJ, Pullen J, Borowitz MJ, Link MP, Amylon M, Behm FG.
Cancer Genet Cytogenet.
1992;
58
(2):
121-4
-
Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study.
Link MP,
Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A, Shuster J.
Clin Orthop Relat Res.
1991;
(270):
8-14
-
Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study.
Goorin AM,
Shuster JJ, Baker A, Horowitz ME, Meyer WH, Link MP.
J Clin Oncol.
1991;
9
(4):
600-5
-
Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias.
Suryanarayan K,
Hunger SP, Kohler S, Carroll AJ, Crist W, Link MP, Cleary ML.
Blood.
1991;
77
(2):
324-30
-
Hodgkin's disease. Treatment of the young child.
Donaldson SS,
Link MP.
Pediatr Clin North Am.
1991;
38
(2):
457-73
-
Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
Diaz PS,
Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM.
Pediatrics.
1991;
87
(2):
166-70
-
Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.
Krischer JP,
Ragab AH, Kun L, Kim TH, Laurent JP, Boyett JM, Cornell CJ, Link M, Luthy AR, Camitta B.
J Neurosurg.
1991;
74
(6):
905-9
-
Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Russo C,
Carroll A, Kohler S, Borowitz M, Amylon M, Homans A, Kedar A, Shuster J, Land V, Crist W.
Blood.
1991;
77
(5):
1050-6
-
The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.
Hunger SP,
Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML.
Blood.
1991;
77
(4):
687-93
-
Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.
Venturelli D,
Mariano MT, Szczylik C, Valtieri M, Lange B, Crist W, Link M, Calabretta B.
Cancer Res.
1990;
50
(22):
7371-5
-
Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Grier HE,
Gelber RD, Clavell LA, Camitta BM, Link MP, Garcea MJ, Weinstein HJ.
Haematol Blood Transfus.
1990:
33
193-7
-
Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood.
Pui CH,
Carroll AJ, Head D, Raimondi SC, Shuster JJ, Crist WM, Link MP, Borowitz MJ, Behm FG, Land VJ.
Blood.
1990;
76
(3):
590-6
-
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study.
Crist W,
Carroll A, Shuster J, Jackson J, Head D, Borowitz M, Behm F, Link M, Steuber P, Ragab A.
Blood.
1990;
76
(3):
489-94
-
Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy.
Link MP,
Donaldson SS, Berard CW, Shuster JJ, Murphy SB.
N Engl J Med.
1990;
322
(17):
1169-74
-
Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes.
Donaldson SS,
Whitaker SJ, Plowman PN, Link MP, Malpas JS.
J Clin Oncol.
1990;
8
(7):
1128-37
-
The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Carroll AJ,
Crist WM, Link MP, Amylon MD, Pullen DJ, Ragab AH, Buchanan GR, Wimmer RS, Vietti TJ.
Blood.
1990;
76
(6):
1220-4
-
Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma.
Carroll WL,
Yu M, Link MP, Korsmeyer SJ.
J Immunol.
1989;
143
(2):
692-8
-
Aggressive management of second primary tumors in survivors of hereditary retinoblastoma.
Smith LM,
Donaldson SS, Egbert PR, Link MP, Bagshaw MA.
Int J Radiat Oncol Biol Phys.
1989;
17
(3):
499-505
-
Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings.
Miller L,
Link MP, Bologna S, Parker BR.
AJR Am J Roentgenol.
1989;
152
(2):
343-4
-
Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
Donaldson SS,
Link MP, McDougall IR, Parker BR, Shochat SJ.
Cancer Treat Res.
1989:
41
307-15
-
Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain.
Wright A,
Lee JE, Link MP, Smith SD, Carroll W, Levy R, Clayberger C, Krensky AM.
J Exp Med.
1989;
169
(5):
1557-64
-
Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Results from the Pediatric Oncology Group and St. Jude Children's Research Hospital.
Hutchison RE,
Murphy SB, Fairclough DL, Shuster JJ, Sullivan MP, Link MP, Donaldson SS, Berard CW.
Cancer.
1989;
64
(1):
23-8
-
Long-term growth of malignant thymocytes in vitro.
Smith SD,
McFall P, Morgan R, Link M, Hecht F, Cleary M, Sklar J.
Blood.
1989;
73
(8):
2182-7
-
Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
Mefferd JM,
Donaldson SS, Link MP.
Int J Radiat Oncol Biol Phys.
1989;
16
(3):
679-85
-
Poor-risk non-lymphoblastic lymphoma of childhood: results of an intensive pilot study.
Finlay JL,
Trigg ME, Link MP, Frierdich S.
Med Pediatr Oncol.
1989;
17
(1):
29-38
-
Small cell osteosarcoma. A clinicopathologic study of 27 cases.
Ayala AG,
Ro JY, Raymond AK, Jaffe N, Chawla S, Carrasco H, Link M, Jimenez J, Edeiken J, Wallace S.
Cancer.
1989;
64
(10):
2162-73
-
Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34.
Smith SD,
Morgan R, Gemmell R, Amylon MD, Link MP, Linker C, Hecht BK, Warnke R, Glader BE, Hecht F.
Blood.
1988;
71
(2):
395-402
-
Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia.
Bird J,
Galili N, Link M, Stites D, Sklar J.
J Exp Med.
1988;
168
(1):
229-45
-
Idiotype as a tumor-specific marker in childhood B cell acute lymphoblastic leukemia.
Carroll WL,
Link MP, Cleary ML, Bologna S, Carswell C, Amylon MD, Smith SD, Levy R.
Blood.
1988;
71
(4):
1068-73
-
Philadelphia chromosome-positive acute lymphoblastic leukemia cell lines without classical breakpoint cluster region rearrangement.
Naumovski L,
Morgan R, Hecht F, Link MP, Glader BE, Smith SD.
Cancer Res.
1988;
48
(10):
2876-9
-
Treatment of osteosarcoma.
Link MP,
Lancet.
1988;
1
(8598):
1334
-
Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance.
Clayberger C,
Wright A, Medeiros LJ, Koller TD, Link MP, Smith SD, Warnke RA, Krensky AM.
Lancet.
1987;
2
(8558):
533-6
-
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.
Donaldson SS,
Link MP.
J Clin Oncol.
1987;
5
(5):
742-9
-
Establishment and characterization of a common acute lymphoblastic leukemia cell line with a deletion of chromosome 3 band q26.
Smith SD,
Morgan R, Galili N, Amylon MD, Link MP, Hecht F, Sklar J, Glader BE.
Cancer Res.
1987;
47
(6):
1652-6
-
Giant cell pneumonia caused by parainfluenza type 3 in a patient with acute myelomonocytic leukemia.
Weintrub PS,
Sullender WM, Lombard C, Link MP, Arvin A.
Arch Pathol Lab Med.
1987;
111
(6):
569-70
-
Improved results of treatment of adult acute lymphoblastic leukemia.
Linker CA,
Levitt LJ, O'Donnell M, Ries CA, Link MP, Forman SJ, Farbstein MJ.
Blood.
1987;
69
(4):
1242-8
-
Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors.
Weinstein H,
Grier H, Gelber R, Camitta B, Link M, Delorey M, Price K.
Haematol Blood Transfus.
1987:
30
88-92
-
Prognostic factors in childhood acute myelogenous leukemia.
Grier HE,
Gelber RD, Camitta BM, Delorey MJ, Link MP, Price KN, Leavitt PR, Weinstein HJ.
J Clin Oncol.
1987;
5
(7):
1026-32
-
Quantitation and estimation of lymphocyte subsets in tissue sections. Comparison with flow cytometry.
Garcia CF,
Weiss LM, Lowder J, Komoroske C, Link MP, Levy R, Warnke RA.
Am J Clin Pathol.
1987;
87
(4):
470-7
-
Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III.
Goorin AM,
Perez-Atayde A, Gebhardt M, Andersen JW, Wilkinson RH, Delorey MJ, Watts H, Link M, Jaffe N, Frei E.
J Clin Oncol.
1987;
5
(8):
1178-84
-
A unique antigen on mature B cells defined by a monoclonal antibody.
Link MP,
Bindl J, Meeker TC, Carswell C, Doss CA, Warnke RA, Levy R.
J Immunol.
1986;
137
(9):
3013-8
-
Adjuvant therapy in the treatment of osteosarcoma.
Link MP,
Important Adv Oncol.
1986:
193-207
-
Chromosome 9 abnormalities in childhood T-cell leukemia.
Smith SD,
Link MP, Trela M, Amylon M, Sklar J, Morgan R, Hecht F.
N Engl J Med.
1986;
315
(3):
195-6
-
Chromosome clues to acute leukemia in Down's syndrome.
Hecht F,
Hecht BK, Morgan R, Sandberg AA, Link MP.
Cancer Genet Cytogenet.
1986;
21
(2):
93-8
-
Chronic infectious mononucleosis syndrome, pancytopenia, and polyclonal B-lymphoproliferation terminating in acute lymphoblastic leukemia.
Finlay J,
Luft B, Yousem S, Wood GS, Link M, Arvin A, Glader B, Lennette E, Shatsky M, Olds L.
Am J Pediatr Hematol Oncol.
1986;
8
(1):
18-27
-
Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development.
Denny CT,
Hollis GF, Hecht F, Morgan R, Link MP, Smith SD, Kirsch IR.
Science.
1986;
234
(4773):
197-200
-
Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma.
Smith SD,
Morgan R, Link MP, McFall P, Hecht F.
Blood.
1986;
67
(3):
650-6
-
Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia.
Weiss LM,
Bindl JM, Picozzi VJ, Link MP, Warnke RA.
Blood.
1986;
67
(2):
474-8
-
Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study.
Bunin NJ,
Hvizdala E, Link M, Callihan TR, Hustu HO, Wharam M, Warnke RA, Berard CW, Murphy SB.
J Clin Oncol.
1986;
4
(2):
154-9
-
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.
Link MP,
Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA.
N Engl J Med.
1986;
314
(25):
1600-6
-
Abnormal helper:suppressor T-cell ratio in the staff of a pediatric hospital.
Somma C,
Miller JJ, Silverman ED, Link MP.
N Engl J Med.
1985;
312
(24):
1573-4
-
Acute leukemias associated with the 4;11 chromosome translocation have rearranged immunoglobulin heavy chain genes.
Crist WM,
Cleary ML, Grossi CE, Prasthofer EF, Heggie GD, Omura GA, Carroll AJ, Link MP, Sklar J.
Blood.
1985;
66
(1):
33-8
-
Conservative management of testicular endodermal sinus tumor in childhood.
Carroll WL,
Kempson RL, Govan DE, Freiha FS, Shochat SJ, Link MP.
J Urol.
1985;
133
(6):
1011-4
-
Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies.
Link MP,
Stewart SJ, Warnke RA, Levy R.
J Clin Invest.
1985;
76
(1):
248-53
-
Immunologic selection of hemopoietic precursor cells utilizing antibody-mediated plate binding ("panning").
Greenberg PL,
Baker S, Link M, Minowada J.
Blood.
1985;
65
(1):
190-7
-
Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome.
Morgan R,
Hecht F, Cleary ML, Sklar J, Link MP.
Blood.
1985;
66
(6):
1466-8
-
Non-Hodgkin's lymphoma in children.
Link MP,
Pediatr Clin North Am.
1985;
32
(3):
699-720
-
A unique human B lymphocyte antigen defined by a monoclonal antibody.
Meeker TC,
Miller RA, Link MP, Bindl J, Warnke R, Levy R.
Hybridoma.
1984;
3
(4):
305-20
-
Acute nonlymphocytic leukemia developing during the course of Ewing's sarcoma.
Link MP,
Donaldson SS, Kempson RL, Wilbur JR, Glader BE.
Med Pediatr Oncol.
1984;
12
(3):
194-200
-
Immune thrombocytopenia associated with acute nonlymphocytic leukemia.
Amylon MD,
Link MP, Glader BE.
J Pediatr.
1984;
105
(5):
776-8
-
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines.
Smith SD,
Shatsky M, Cohen PS, Warnke R, Link MP, Glader BE.
Cancer Res.
1984;
44
(12 Pt 1):
5657-60
-
Pan-leukocyte monoclonal antibody L3B12. Characterization and application to research and diagnostic problems.
Wood GS,
Link M, Warnke RA, Dilley J, Levy R.
Am J Clin Pathol.
1984;
81
(2):
176-83
-
Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients.
Goorin AM,
Delorey MJ, Lack EE, Gelber RD, Price K, Cassady JR, Levey R, Tapper D, Jaffe N, Link M.
J Clin Oncol.
1984;
2
(5):
425-31
-
Thyroid dysfunction after radiotherapy in children with Hodgkin's disease.
Constine LS,
Donaldson SS, McDougall IR, Cox RS, Link MP, Kaplan HS.
Cancer.
1984;
53
(4):
878-83
-
A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies.
Link M,
Warnke R, Finlay J, Amylon M, Miller R, Dilley J, Levy R.
Blood.
1983;
62
(4):
722-8
-
Cranial nerve involvement in children with leukemia and lymphoma.
Paryani SB,
Donaldson SS, Amylon MD, Link MP.
J Clin Oncol.
1983;
1
(9):
542-5
-
Cutaneous lymphoblastic lymphoma with pre-B markers.
Link MP,
Roper M, Dorfman RF, Crist WM, Cooper MD, Levy R.
Blood.
1983;
61
(5):
838-41
-
Identification and significance of cell markers in leukemia and lymphoma.
Warnke RA,
Link MP.
Annu Rev Med.
1983:
34
117-31
-
Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
Abelson HT,
Fosburg MT, Beardsley GP, Goorin AM, Gorka C, Link M, Link D.
J Clin Oncol.
1983;
1
(3):
208-16
-
Fetal-like erythropoiesis during recovery from transient erythroblastopenia of childhood (TEC).
Link MP,
Alter BP.
Pediatr Res.
1981;
15
(7):
1036-9
-
High-dose methotrexate in osteogenic sarcoma adjuvant chemotherapy and limb salvage results.
Jaffe N,
Goorin A, Link M, Watts H, Frei E, Vawter G, Fellows KE, Beardsley GP, Abelson HT.
Cancer Treat Rep.
1981:
65 Suppl 1
99-106
-
High-dose methotrexate in osteogenic sarcoma.
Jaffe N,
Link MP, Cohen D, Traggis D, Frei E, Watts H, Beardsley GP, Abelson HT.
Natl Cancer Inst Monogr.
1981;
(56):
201-6
-
Non-Hodgkin's lymphoma in childhood.
Weinstein HJ,
Link MP.
Clin Haematol.
1979;
8
(3):
699-716
Navigation for This Section: Neonatal & Developmental Medicine
Find a Researcher
Help